Rate of disease progression during long-term follow-up of patients with late-onset Pompe disease

N. A. M. E. Van der Beek*, M. L. C. Hagemans, A. J. J. Reuser, W. C. J. Hop, A. T. Van der Ploeg, P. A. Van Doorn, J. H. J. Wokke

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

78 Citations (Scopus)

Abstract

To determine the rate of disease progression in patients with late-onset Pompe disease, we collected longitudinal data on pulmonary function and skeletal muscle strength in 16 patients whose symptoms had started in childhood or adulthood. The mean duration of follow-up was 16 years (range 4-29 years). During the follow-up period, eight patients (50%) became wheelchair bound and three (19%) became ventilator dependent. At a group level, pulmonary function deteriorated by 1.6% per year, and proximal muscle weakness progressed gradually. At the individual level, however, the rate and extent of progression varied highly between patients. In two thirds of patients, pulmonary function and muscle strength declined simultaneously and to the same extent. The remaining one third of patients showed a variable, sometimes rapidly progressive Course, leading to early respirator or wheelchair dependency. These individual differences, especially in pulmonary dysfunction, indicate the need for regular monitoring every 6-12 months depending on the rate of disease progression. (C) 2008 Elsevier B.V. All rights reserved

Original languageEnglish
Pages (from-to)113-117
Number of pages5
JournalNeuromuscular disorders
Volume19
Issue number2
DOIs
Publication statusPublished - Feb-2009

Keywords

  • Pompe disease
  • Glycogen storage disease type II
  • Acid alpha-glucosidase
  • Late-onset
  • Disease progression
  • ACID MALTASE DEFICIENCY
  • GENOTYPE-PHENOTYPE CORRELATION
  • HUMAN ALPHA-GLUCOSIDASE
  • RESPIRATORY-FAILURE
  • CLINICAL-TRIAL
  • NATURAL COURSE
  • FREQUENCY
  • SPECTRUM
  • DIAGNOSIS
  • MUTATION

Cite this